NCT05848180

Ankle Proprioceptive Training In Patients With Diabetic Peripheral Neuropathy

Completed NA Last updated 12 October 2023

What this trial tests

NA trial testing Ankle proprioceptive training (APT) in Diabetic Peripheral Neuropathy in 62 participants. Completed in 30 September 2023.

Timeline

5 May 2023

Primary endpoint
30 August 2023

30 September 2023

Quick facts

Lead sponsor	Riphah International University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	62
Start date	5 May 2023
Primary completion	30 August 2023
Estimated completion	30 September 2023
Sites	1 location across Pakistan

Drugs / interventions tested

• Ankle proprioceptive training (APT)
• Balance training (BT)

Conditions studied

• Diabetic Peripheral Neuropathy — all drugs for Diabetic Peripheral Neuropathy →

Sponsor

Riphah International University

Who can join

Adults 40 to 60, any sex, with Diabetic Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetes being a very prevalent condition results in various complications including neuropathy, which can impair various functional outcomes in patients including balance. Ankle proprioceptive training (APT) is an intervention that is used to tackle this problem. The study will compare APT with standard balance training in subjects with diabetic neuropathy.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.